Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2024-09-23 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
关于新增2024年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the addition of expected daily related-party transactions for the year 2024 by Guangdong Driving Force Biotechnology Group Co., Ltd. It details the nature, amounts, counterparties, and rationale for these related-party transactions. The document includes disclosures about the pricing policy, fairness, and necessity of these transactions, as well as the opinion of the sponsoring institution. It is a regulatory announcement about related-party transactions rather than a financial report or earnings release. It does not contain financial statements or management discussion of results, nor is it a voting result or board change announcement. The document fits best into the category of Regulatory Filings (RNS) as it is a compliance disclosure about related-party transactions required by stock exchange rules.
2024-09-23 Chinese
华安证券股份有限公司关于广东驱动力生物科技集团股份有限公司新增2024年预计日常性关联交易的专项核查意见
Regulatory Filings
2024-09-23 Chinese
北京市中伦（广州）律师事务所关于广东驱动力生物科技集团股份有限公司 2024 年第二次临时股东大会的法律意见书
Regulatory Filings
2024-09-17 Chinese
2024年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the "2024 Second Extraordinary General Meeting of Shareholders" of Guangdong Drive Biological Technology Group Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on shareholder meeting resolutions, voting outcomes, and governance changes such as amendments to the company's articles and governance systems. There is no financial data, earnings information, or report publication mentioned. The document is clearly an official announcement of voting results from a shareholders' meeting, fitting the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2406 characters, which is consistent with an announcement rather than a full report.
2024-09-17 Chinese
《公司章程》
Governance Information Classification · 95% confidence The document is a detailed corporate charter or articles of association for Guangdong Drive Biological Technology Group Co., Ltd. It includes chapters on company general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, senior management, supervisory board, information disclosure, financial accounting system, profit distribution and audit, notices, mergers, amendments to the charter, litigation, and appendices. The content is focused on governance structure, shareholder rights, meeting procedures, and company regulations. There is no indication of financial statements, audit reports, earnings data, or announcements of voting results. The document is a governance-related document detailing internal rules and company structure. Therefore, it fits best under Governance Information (CGR).
2024-09-17 Chinese
投资者关系活动记录表
Call Transcript Classification · 90% confidence The document is an investor relations activity record from Guangdong Drive Biological Technology Group Co., Ltd. It details a Q&A session held online with investors on September 12, 2024, including discussions about dividend policy, half-year gross margin changes, and profit performance. The content is a transcript or summary of an investor relations event rather than a formal financial report or earnings release. It is not a full earnings release (ER) because it contains detailed Q&A rather than just key highlights. It is not an investor presentation (IP) because it is not a prepared presentation but a record of interaction. It is not an interim or quarterly report (IR) because it lacks formal financial statements or substantive financial data. The document is best classified as a Call Transcript (CT) type, as it records a company-investor interaction session with Q&A, similar to earnings call transcripts.
2024-09-12 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.